How Can Cardiac Damage Be Prevented During Cancer Treatment?
Prevention strategies focus on minimizing exposure to cardiotoxic agents and vigilant monitoring. Dose modifications, the use of cardioprotective agents like dexrazoxane, and employing alternative therapies with lower cardiotoxic potential can help mitigate risks. Close monitoring with echocardiograms or cardiac biomarkers allows for early detection of cardiac changes, enabling prompt intervention.
